Doxycycline | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Grow Your Pharma Business Digitally

X

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Doxycycline
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Doxycycline

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 11 USDMF, 8 CEP/COS, 5 KDMF, 7 NDC API, 13 Listed Suppliers, $ API Reference Price

27 API Suppliers
11 USDMF
8 CEP/COS
5 KDMF
7 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

FINISHED DOSAGE FORMULATIONS

226 FDF Dossiers, 79 FDA Orange Book, 36 Europe, 2 Canada, 58 Australia, 13 South Africa, 38 Listed Dossiers

226 FDF Dossiers
79 FDA Orange Book
36 Europe
2 Canada
58 Australia
13 South Africa
38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 150MG BASE, CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE, CAPSULE;ORAL - 40MG

CAPSULE;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 150MG BASE
CAPSULE;ORAL - EQ 50MG BASE
CAPSULE;ORAL - EQ 75MG BASE
CAPSULE;ORAL - 40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 3 Rochem International Inc, 7 SPI Pharma, 12 DKSH, 7 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 34 BASF, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 13 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 38 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 32 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 75 Coating Systems & Additives, 42 Controlled & Modified Release, 41 Thickeners and Stabilizers, 40 Disintegrants & Superdisintegrants, 33 Solubilizers, 32 Direct Compression, 31 Granulation, 29 Film Formers & Plasticizers, 22 Taste Masking, 21 Parenteral, 19 Topical, 17 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 11 Rheology Modifiers, 9 Empty Capsules, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

85 Fillers, Diluents & Binders
75 Coating Systems & Additives
42 Controlled & Modified Release
41 Thickeners and Stabilizers
40 Disintegrants & Superdisintegrants
33 Solubilizers
32 Direct Compression
31 Granulation
29 Film Formers & Plasticizers
22 Taste Masking
21 Parenteral
19 Topical
17 Lubricants & Glidants
13 Co-Processed Excipients
12 Chewable & Orodispersible Aids
11 Rheology Modifiers
9 Empty Capsules
8 Emulsifying Agents
6 API Stability Enhancers
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 47 News #PharmaBuzz

1 Data Compilation #PharmaFlow
47 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 51 Regulatory FDF Prices

5 US Medicaid Prescriptions
51 Regulatory FDF Prices

MARKET PLACE

38 APIs, 8 FDF Dossiers, 1 Intermediates

38 APIs
8 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

2 US Patents, 3 Health Canada Patents

2 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

2 EDQM
2 USP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 81 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2GALDERMA LABS LP

filter Patent Number Reset all filters

2 All

01 17749532

02 18206740

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 12025-12-24

02 12027-12-19

Product Main Page

01

GALDERMA LABS LP

ELCC

Not Confirmed

GALDERMA LABS LP

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-24

DOXYCYCLINE

US Patent Number : 8206740

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50805

Patent Use Code : U-925

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2025-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GALDERMA LABS LP

ELCC

Not Confirmed

GALDERMA LABS LP

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-19

DOXYCYCLINE

US Patent Number : 7749532

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50805

Patent Use Code : U-1063

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2027-12-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!